77 related articles for article (PubMed ID: 2886569)
21. Dose-response studies of indenolol, a beta adrenoceptor blocker.
Okupa FE; Daneshmend TK; Shrosbree E; Roberts CJ
Clin Pharmacol Ther; 1981 Apr; 29(4):434-9. PubMed ID: 6110504
[TBL] [Abstract][Full Text] [Related]
22. Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension.
Bono M; Cases A; Calls J; Gaya J; Jiménez W; Carretero J; Rivera F; Revert L
Am J Hypertens; 1995 May; 8(5 Pt 1):487-93. PubMed ID: 7662225
[TBL] [Abstract][Full Text] [Related]
23. Haemodynamic effects of indenolol at rest and after a submaximal workload in essential hypertension.
Aiello C; Groothold G; Gualtieri S; Irace L; Marini IL; Perna B; Romano A
Eur J Clin Pharmacol; 1985; 28(5):501-5. PubMed ID: 3899670
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of a new antihypertensive agent (indenolol) assessed by ambulatory blood pressure monitoring.
Trimarco B; Groothold G; Bonaduce D; Cuocolo A; Ricciardelli B; Canonico V; Breglio R; Condorelli M
Clin Exp Hypertens A; 1985; 7(2-3):395-9. PubMed ID: 2860987
[TBL] [Abstract][Full Text] [Related]
25. Effects of indenolol on blood pressure, lower limb blood flow, adrenergic reflexes, and plasma renin activity.
Poggesi L; Masotti G; Boddi M; Neri Serneri GG
Clin Pharmacol Ther; 1987 Mar; 41(3):344-50. PubMed ID: 2880689
[TBL] [Abstract][Full Text] [Related]
26. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
27. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
[TBL] [Abstract][Full Text] [Related]
28. Some central effects of indenolol in experimental animals.
Tariq M; Babhair SA; Ageel AM; Ginawi OT; Parmar NS
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):201-9. PubMed ID: 2878478
[TBL] [Abstract][Full Text] [Related]
29. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Dorow P
Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
[TBL] [Abstract][Full Text] [Related]
30. Beta-adrenergic receptors on polymorphonuclear cell membranes in essential hypertension.
Eliahou HE; Serban I; Gavendo S; Kapuler S; Farfel Z; Iaina A
J Clin Hypertens; 1985 Jun; 1(2):132-7. PubMed ID: 3014077
[TBL] [Abstract][Full Text] [Related]
31. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
Milne BJ; Logan AG
Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[TBL] [Abstract][Full Text] [Related]
33. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
[TBL] [Abstract][Full Text] [Related]
34. Is verapamil also a non-selective beta blocker?
Drici MD; Jacomet Y; Iacono P; Lapalus P
Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):27-30. PubMed ID: 8095251
[TBL] [Abstract][Full Text] [Related]
35. Remission of mild to moderate hypertension after treatment with carteolol, a beta-adrenoceptor blocker with intrinsic sympathomimetic activity.
Giles TD; Sander GE; Roffidal L; Thomas MG; Mersch DP; Moyer RR; Burris JF; Mroczek WJ; Brachfeld J
Arch Intern Med; 1988 Aug; 148(8):1725-8. PubMed ID: 3041936
[TBL] [Abstract][Full Text] [Related]
36. Treatment of mild and moderate hypertension with medroxalol, an alpha- and beta-adrenergic antagonist.
Schechter PJ; Tanskanen A; Tuomilehto J; Koch-Weser J
J Cardiovasc Pharmacol; 1982; 4(6):955-9. PubMed ID: 6185788
[TBL] [Abstract][Full Text] [Related]
37. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
38. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on blood pressure in hypertensive patients known to respond to beta 1-adrenoceptor antagonists.
Robb OJ; Webster J; Petrie JC; Harry JD; Young J
Br J Clin Pharmacol; 1988 Apr; 25(4):433-8. PubMed ID: 2898256
[TBL] [Abstract][Full Text] [Related]
39. The hemodynamics and hemodynamic effects of indenolol in mild hypertension.
Hashimoto Y; Tamaki H; Hosaka T; Maezawa H
Jpn Heart J; 1984 Nov; 25(6):1029-45. PubMed ID: 6530747
[TBL] [Abstract][Full Text] [Related]
40. [Effect of physical load and brief monotherapy with obsidan on the characteristics of beta 2-adrenoreceptors of intact lymphocytes in patients with hypertension].
Parfenova EV; Nauman E; Korichneva IL; Suvorov IuI; Aripova NA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):60-8. PubMed ID: 2840928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
